This inventor holds 28 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 8 EPO patents, primarily in RNA Interference. Top assignees: Silence Therapeutics Gmbh, Chiron Corporation, Quark Pharmaceuticals, Inc.. Active years: 1998-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Castro Valley, CA (US) (1998)
- San Francisco, CA (US) (2003 - 2010)
- Berlin, DE (2002 - 2023)
Company Filing History:
12 out of 38 
4 out of 672 
4 out of 67 Years Active: 1998-2026
Areas of Expertise:
Title: Klaus Giese: Innovator in RNA Technology
Introduction: Klaus Giese, based in Berlin, Germany, is an accomplished inventor specializing in the field of ribonucleic acid (RNA) technology. With a remarkable portfolio of 27 patents, Giese has significantly contributed to the scientific community through his innovative ideas and inventions.
Latest Patents: Among his notable patents, Giese has developed interfering RNA molecules, which consist of a double-stranded structure. This innovation includes a first strand that is partially complementary to a target nucleic acid and a second strand that is partially identical to a target nucleic acid, with the double-stranded structure being blunt-ended. This invention showcases Giese's expertise in manipulating RNA for potential therapeutic applications.
Career Highlights: Throughout his career, Klaus Giese has worked with prominent companies such as Silence Therapeutics GmbH and Silence Therapeutics Aktiengesellschaft. These roles have allowed him to advance his research and bring his patented inventions to fruition within the biotech industry.
Collaborations: Giese has also collaborated with several prominent professionals in his field, including Jörg Kaufmann and Anke Klippel-Giese. These collaborations have likely enhanced his innovative capabilities and facilitated the development of groundbreaking RNA technologies.
Conclusion: Klaus Giese stands out as a key figure in RNA research and innovation. His extensive patent portfolio reflects his commitment to advancing scientific understanding and technology. As he continues to push the boundaries of RNA technology, Giese's contributions will undoubtedly shape the future of genetic research and therapeutic development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile